[Inhibition of nitric oxide synthase in septic shock. Therapeutic limits and perspectives].
Endres
S
S
Medizinische Klinik, Kinikum Innenstadt der Ludwig-Maximillians-Universität, München.
Eigler
A
A
D000818:Animals; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D019331:NG-Nitroarginine Methyl Ester / Q000009:adverse effects / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000502:physiology; D012772:Shock, Septic / Q000188:drug therapy* / Q000201:enzymology; D019323:omega-N-Methylarginine / Q000009:adverse effects / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester